Excelra Expands Bioinformatics Services with Fios Genomics Team Incorporation
Excelra Expands Bioinformatics Services with Fios Genomics Team Incorporation
On October 20, 2026, Excelra, a prominent player in the field of scientific informatics, finalized the transition of the bioinformatics services and team from Fios Genomics Ltd. This collaboration marks a significant step in enhancing Excelra's capabilities in omics analytics and expands its footprint within the European market, particularly in the UK.
Fios Genomics, which has its roots in Edinburgh, Scotland, has spent nearly twenty years transforming intricate omics data into meaningful insights for pharmaceutical, biotech, and life sciences sectors. The company's expertise shines particularly in the realm of multi-omics study analysis, a critical area that addresses complex biological questions across a variety of research initiatives.
This move sees Fios Genomics becoming part of Excelra's comprehensive scientific consulting group, where they intend to maintain their established client relationships while leveraging the wider resources and expertise that Excelra offers. As Sarah Lynagh, the CEO of Fios Genomics, stated, the essence of this transition is about maintaining continuity to allow for an even greater impact:
“Fios has always been defined by the quality of its science and the care we take with each study. Excelra shares those values and brings the wider data science and scientific informatics capability to do more for the researchers we work with.”
In echoing this sentiment, Jannick Bendtsen, Vice President of Bioinformatics at Excelra, emphasized the alignment of Fios’s operational ethos with Excelra’s strategic focus on integrative multi-omics, translational insights, and scientific AI. He noted the synergy between both teams when it comes to rapid and clear data analysis, which meets the urgent needs scientists have when tackling a fresh dataset.
Commenting on the remarkable transition, Anandbir Singh Brar, Chief Executive Officer of Excelra, welcomed the seasoned bioinformatics team from Fios Genomics, highlighting the rapid growth of omics data and the enduring nature of the scientific questions that arise:
“Pairs Fios' scientific depth with our own bioinformatics, data, and AI-native engineering means we can answer those questions even faster and with more confidence.”
Fios Genomics was founded in 2008 as a spin-out from the University of Edinburgh. In the years since, it has carved out a reputation for delivering comprehensive bioinformatics analysis and biological interpretation across multiple omics domains. The firm has continued to serve the global research community by aiding them in unlocking the invaluable insights embedded in complex biological datasets.
The integration into Excelra is expected to significantly enhance service delivery for existing Fios clients. Leveraging Excelra's advanced data assets, AI-driven engineering, and an extensive pool of domain specialists, the combined group aims to bolster its research capabilities. This strategic move not only aligns with Excelra's growth trajectory but also underscores the importance of delivering high-quality scientific services tailored to the evolving landscape of disease research and drug development.
Clients from Fios can continue to reach the dedicated team for their ongoing projects, ensuring a stable transition as they evolve under the umbrella of Excelra.
About Excelra
Excelra is an innovative scientific informatics firm focused on enhancing research and development through AI-driven solutions. They utilize AI-ready data and advanced platforms, including GOSTAR, connected lab informatics, and multi-omics expertise, to transform the complexities of R&D into defensible decisions. Their approach is rooted in scientific rigor, data-based methodologies, and a commitment to outcome-oriented research.
About Fios Genomics
Founded in 2008, Fios Genomics has been at the forefront of providing bioinformatics services tailored to the needs of pharma, biotech, and life sciences researchers globally. Their domain expertise spans genomics, transcriptomics, and multi-omics studies, delivering actionable insights crucial for advancing the scientific landscape.
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.